COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.
Scand J Immunol
; 93(3): e12977, 2021 Mar.
Article
em En
| MEDLINE
| ID: mdl-32931622
In the natural history of SARS-CoV-2 infection, liver injury is frequent but quite mild and it is defined as any liver damage occurring during disease progression and treatment of infection in patients with or without pre-existing liver diseases. The underlying mechanisms for hepatic injury in patients with COVID-19 are still unclear but the liver damage in SARS-CoV-2 infection seems to be directly caused by virus-induced cytopathic effects. In this review, we will summarize all data of updated literature, regarding the relationship between SARS-CoV-2 infection, acute response and liver involvement. An overview will be given on liver injury, liver transplant and the possible consequences of COVID-19 in patients with pre-existing liver diseases.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Síndrome da Liberação de Citocina
/
SARS-CoV-2
/
COVID-19
/
Fígado
/
Hepatopatias
Limite:
Humans
Idioma:
En
Revista:
Scand J Immunol
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Itália